CLINICAL STUDY: HYPERTROPHIC CARDIOMYOPATHY
Long-term outcome in patients with apical hypertrophic cardiomyopathy
Maria J. Eriksson, MD, PhD*,
Brian Sonnenberg, MD*,
Anna Woo, MD, FACC*,
Paul Rakowski*,
Thomas G. Parker, MD, FACC*,
E. Douglas Wigle, MD, FACC* and
Harry Rakowski, MD, FACC*,*
* Division of Cardiology, University Hospital Network Toronto General Hospital, University of Toronto, Toronto, Canada
Manuscript received July 31, 2001;
revised manuscript received October 29, 2001,
accepted November 13, 2001.
* Reprint requests and correspondence: Dr. Harry Rakowski, Division of Cardiology, Toronto General Hospital, 12EN-212, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada.
harry.rakowski{at}uhn.on.ca
OBJECTIVES: The aim of this study was to describe long-term outcome in patients with apical hypertrophic cardiomyopathy (ApHCM) followed in a tertiary referral center.
BACKGROUND: Apical hypertrophic cardiomyopathy is a relatively rare form of hypertrophic cardiomyopathy (HCM), first described in Japan. Initial reports, based on a limited number of patients, emphasized the benign nature of this condition.
METHODS: A retrospective study of 105 patients with ApHCM diagnosed at the Toronto General Hospital from 1975 to 2000 was performed. Symptoms, clinical findings, mortality and cardiovascular morbidity were analyzed.
RESULTS: The mean age at presentation was 41.4 ± 14.5 years. During a mean follow-up of 13.6 ± 8.3 years from presentation, cardiovascular mortality was 1.9% (2/105) and annual cardiovascular mortality was 0.1%. Overall survival was 95% at 15 years. Thirty-two patients (30%) had one or more major morbid events, the most frequent being atrial fibrillation (12%) and myocardial infarction (10%). Probability of survival without morbid events was 74% at 15 years. Three predictors of cardiovascular morbidity were identified: age at presentation <41 years, left atrial enlargement, and New York Heart Association (NYHA) class  II at baseline. Forty-four percent of the patients were asymptomatic at the time of last follow-up.
CONCLUSIONS: Apical hypertrophic cardiomyopathy in North American patients is not associated with sudden cardiac death and has a benign prognosis in terms of cardiovascular mortality. Nevertheless, one third of these patients experience serious cardiovascular complications, such as myocardial infarction and arrhythmias. These data are likely to influence the counseling and management of patients with ApHCM.
|
Abbreviations and Acronyms
| | ApHEM | | AF | | atrial fibrillation | | ApHCM | | apical hypertrophic cardiomyopathy | | ECG | | electrocardiogram | | echo | | echocardiography | | HCM | | hypertrophic cardiomyopathy | | LV | | left ventricle | | LVH | | left ventricular hypertrophy | | NSVT | | non-sustained ventricular tachycardia | | NYHA | | New York Heart Association | | VT | | ventricular tachycardia |
|
This article has been cited by other articles:
|
|
|
|
 
I. Ahmed, S. J Smalley, D. W X Zhu, R. Dahiya, C. M House, and W. B Nelson
Sudden cardiac arrest in apical hypertrophic cardiomyopathy
BMJ Case Reports,
September 6, 2009;
2009(sep06_1):
bcr0420091753 - bcr0420091753.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Attili, G. C. Mueller, and S. M. Day
AJR Teaching File: Asymptomatic Man with Giant Negative T Waves on ECG
Am. J. Roentgenol.,
March 1, 2009;
192(3_Supplement):
S57 - S61.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Olearczyk, N. Gollol-Raju, and D. J. Menzies
Apical Hypertrophic Cardiomyopathy Mimicking Acute Coronary Syndrome: A Case Report and Review of the Literature
Angiology,
October 1, 2008;
59(5):
629 - 631.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol.,
December 1, 2007;
189(6):
1335 - 1343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Refaat
Prognosis of Apical Hypertrophic Cardiomyopathy
JAMA,
November 7, 2007;
298(17):
2006 - 2006.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron and P. Spirito
Prognosis of Apical Hypertrophic Cardiomyopathy Reply
JAMA,
November 7, 2007;
298(17):
2006 - 2006.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Spirito and C. Autore
Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis
Eur. Heart J.,
August 2, 2007;
28(16):
1923 - 1924.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nasermoaddeli, K. Miura, A. Matsumori, Y. Soyama, Y. Morikawa, A. Kitabatake, Y. Inaba, and H. Nakagawa
Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study
Heart,
June 1, 2007;
93(6):
711 - 715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J McMahon, R. H Pignatelli, S. F Nagueh, V.-V. Lee, W. Vaughn, S. O Valdes, J. P Kovalchin, J Lynn Jefferies, W. J Dreyer, S. W Denfield, et al.
Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation
Heart,
June 1, 2007;
93(6):
676 - 681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-W. Ha, J.-R. Cho, J.-M. Kim, J.-A. Ahn, E.-Y. Choi, S.-M. Kang, S.-J. Rim, and N. Chung
Tissue Doppler-Derived Indices Predict Exercise Capacity in Patients With Apical Hypertrophic Cardiomyopathy
Chest,
November 1, 2005;
128(5):
3428 - 3433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Arad, M. Penas-Lado, L. Monserrat, B. J. Maron, M. Sherrid, C. Y. Ho, S. Barr, A. Karim, T. M. Olson, M. Kamisago, et al.
Gene Mutations in Apical Hypertrophic Cardiomyopathy
Circulation,
November 1, 2005;
112(18):
2805 - 2811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J C C Moon, N G Fisher, W J McKenna, and D J Pennell
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography
Heart,
June 1, 2004;
90(6):
645 - 649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1687 - 1713.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J.,
November 1, 2003;
24(21):
1965 - 1991.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Matsubara, T. Nakamura, T. Kuribayashi, A. Azuma, and M. Nakagawa
Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
July 16, 2003;
42(2):
288 - 295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. G. Abinader
Long-term outcome in patients with apical hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
August 21, 2002;
40(4):
837 - 838.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Rakowski, M. J. Eriksson, and E. D. Wigle
Reply
J. Am. Coll. Cardiol.,
August 21, 2002;
40(4):
838 - 838.
[Full Text]
[PDF]
|
|
|
|
